Product Reports Resources Pricing Login Book a demo

Broken String Biosciences

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2020

Enhancing the safety of cell and gene therapies through comprehensive genome stability assessments MoreLess

Broken String Biosciences is a genomics company that operates in the biotechnology sector. The company is developing a technology platform that speeds up the characterization of new genome editing technologies. This is expected to pave the way for the next generation of cell and gene therapies. The company's vision is to make these therapies safer, more efficient, and affordable for patients.

The company's primary technology, INDUCE-seq™, is a DNA break mapping technology. This technology provides detailed information about how genome editors interact with and modify our genomes. This information is crucial for the efficient development of new genome editing systems and will open up many new targets within the genome for therapeutic development.

Broken String Biosciences serves clients in the biotechnology and healthcare sectors, including scientific leaders and world-renowned organizations. The company's business model is based on partnerships and collaborations to further develop and apply its technology.

The company generates revenue by licensing its technology to other companies and research institutions. It also makes money by providing services related to its technology, such as data analysis and consulting.

Broken String Biosciences is backed by Illumina and Tencent and is based at the Wellcome Genome Campus in Cambridge, UK. The company recently appointed Gavin Burns as Vice President of Quality and Operations, indicating a focus on quality assurance and operational efficiency.

Keywords: Genomics, Biotechnology, Genome Editing, Cell Therapy, Gene Therapy, INDUCE-seq™, DNA Break Mapping, Partnerships, Illumina, Tencent.

Company overview

Broken String Biosciences company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
Cambridge, United Kingdom
Employees
35
Open positions
None listed
Dealroom signal
71.1
client focusb2btechnologyArtificial Intelligencesub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorGenetics and genomicssectorSequencingsectorCore AIsectorSpinoutsectorGenome EngineeringsectorAI Drug DiscoverysectorTechbiosectorHard Tech

Valuation & funding

Broken String Biosciences funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Oct 2025 $5.9M $77M Undisclosed
GRANTOther financing Jul 2025 $331K UK Research and Innovation
SERIES AEquity / VC Sep 2023 $15M $62M Dieter von Holtzbrinck Ventures · Illumina Ventures · HERAN Partners · Tencent
SEEDEquity / VC Sep 2021 $4M $16M Illumina Ventures
SEEDEquity / VC Feb 2021 $0 Illumina Ventures
SPINOUTOther financing Jan 2020 Cardiff University
Showing 6 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 35
2025 31
2024 42
2023 26
2022 12
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Broken String Biosciences website traffic

Latest recorded traffic for Broken String Biosciences is 5K monthly website visits, up 100% over the last three months. Broken String Biosciences's team grew 12.9% over the past year.

Latest monthly visits5K 3-month web change+100% 1-year team growth+12.9%
Monthly website visits39 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Broken String Biosciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Broken String Biosciences's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Broken String Biosciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Illumina Ventures
UK Research and Innovation
Series A 4 investors entered at this stage
Mérieux Equity Partners
Dieter von Holtzbrinck Ventures
HERAN Partners
Tencent
Other known 2 additional known investors
Cardiff University
First In Ventures

Global footprint

Where Broken String Biosciences has talent and traffic

Workforce by country
7 countries with
team presence
🇬🇧 United Kingdom58.1%
🇺🇸 United States22.6%
🇫🇷 France6.5%
🇨🇳 China3.2%
🇧🇪 Belgium3.2%
Top 5 of 7 shown

In the news

Latest news about Broken String Biosciences

Recent press, funding announcements, and product moves mentioning Broken String Biosciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Broken String Biosciences

An AI-synthesized read of the highest-engagement posts about Broken String Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Broken String Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.